Skip to main content
Signal8

Carver Kyle

SEC insider (Form 3/4/5 filer). CIK 0001757072. Chief Financial Officer at Evommune, Inc. (EVMN). 7 reported Form 4/5 transactions since Sep 2024; latest on Jul 8, 2026. Located in PALO ALTO, CA.

Companies Carver Kyle has filed insider reports for

  • Evommune, Inc. (EVMN): Officer, Chief Financial Officer
Carver Kyle profile photo

Carver Kyle

CIK: 0001757072

Transaction Breakdown

Open Market Buys (P)1 (14.3%)

High conviction signal

Open Market Sales (S)1 (14.3%)

Position reduction

Option Exercises (M)1 (14.3%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Evommune, Inc. logo
EVMN

Evommune, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Jul 8, 2026
    Purchase
    Direct
    1K shares at avg. $13.26$13K
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    May 28, 2026
    Exercise
    Direct
    15K shares at avg. $2.99$45K
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    May 28, 2026
    Sale
    Direct
    18.2K shares at avg. $22.84$415K
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Apr 16, 2026
    Award

    Employee Stock Option (Right to Buy)

    Direct
    98.9K shares-
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Dec 9, 2025
    Tax Payment
    Direct
    13.3K shares at avg. $17.84$237K
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Nov 7, 2025
    Conversion
    Direct
    3.2K shares-
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Nov 5, 2025
    Award

    Employee Stock Option (Right to Buy)

    Direct
    279.4K shares-

1-7 of 7